US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist

4.830
-0.170-3.40%

Close Nov 15 16:00 ET

4.630
-0.200-4.14%

Post 16:25 ET

42.95MMarket Cap-80500P/E (TTM)

Serina Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

-83.55%500K

3.04M

Operating revenue

--0

-83.55%500K

--3.04M

Cost of revenue

Gross profit

Operating expense

263.09%5.31M

309.10%3.87M

141.27%2.32M

1.46M

945K

962K

-40.69%2.77M

4.67M

Selling and administrative expenses

227.45%2.91M

391.12%2.32M

105.73%1.22M

--889K

--473K

--593K

-0.68%1.29M

--1.3M

-General and administrative expense

227.45%2.91M

391.12%2.32M

105.73%1.22M

--889K

--473K

--593K

-0.68%1.29M

--1.3M

Research and development costs

300.50%2.42M

232.78%1.59M

177.19%1.11M

--603K

--479K

--399K

-58.59%1.57M

--3.8M

Other operating expenses

51.72%-14K

-628.57%-51K

83.33%-5K

---29K

---7K

---30K

78.50%-91.5K

---425.57K

Operating profit

-263.09%-5.31M

-309.10%-3.87M

-141.27%-2.32M

-1.46M

-945K

-962K

-39.16%-2.27M

-1.63M

Net non-operating interest income expense

84.00%-16K

-124.07%-242K

-15.12%-99K

-100K

-108K

-86K

-281.85%-14.12K

7.77K

Non-operating interest income

----

-83.82%1.76K

--10.86K

Non-operating interest expense

-84.00%16K

124.07%242K

15.12%99K

--100K

--108K

--86K

413.19%15.88K

--3.09K

Other net income (expense)

102.44%6.71M

398.93%9.29M

-359.31%-7.02M

3.32M

1.86M

2.71M

-210.75%-397.62K

359.04K

Gain on sale of security

107.76%6.67M

399.41%9.29M

-359.31%-7.02M

--3.21M

--1.86M

--2.71M

-300.52%-398.7K

--198.84K

Special income (charges)

----

--0

--160.21K

-Less:Other special charges

----

---187.13K

-Gain on sale of business

----

--0

---26.93K

Other non- operating income (expenses)

-60.00%42K

---9K

----

--105K

----

--1.08K

----

Income before tax

-21.06%1.38M

540.72%5.18M

-669.18%-9.44M

1.75M

808K

1.66M

-112.07%-2.68M

-1.26M

Income tax

Net income

-21.06%1.38M

540.72%5.18M

-669.18%-9.44M

1.75M

808K

1.66M

-112.07%-2.68M

-1.26M

Net income continuous Operations

-21.06%1.38M

540.72%5.18M

-669.18%-9.44M

--1.75M

--808K

--1.66M

-112.07%-2.68M

---1.26M

Minority interest income

-27K

Net income attributable to the parent company

-19.52%1.41M

544.06%5.2M

-669.18%-9.44M

1.75M

808K

1.66M

-112.07%-2.68M

-1.26M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-19.52%1.41M

544.06%5.2M

-669.18%-9.44M

1.75M

808K

1.66M

-112.07%-2.68M

-1.26M

Basic earnings per share

-80.00%0.16

65.33%0.61

-538.96%-3.38

0.8

0.369

0.77

-112.07%-1.2326

-0.5812

Diluted earnings per share

-43.48%0.13

366.00%0.51

-1,790.00%-3.38

0.23

0.1094

0.2

-112.07%-1.2326

-0.5812

Dividend per share

Currency Unit

USD

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	0	0	0	-83.55%500K	3.04M
Operating revenue	--0	--0	--0	--0	--0	--0	-83.55%500K	--3.04M
Cost of revenue
Gross profit
Operating expense	263.09%5.31M	309.10%3.87M	141.27%2.32M	1.46M	945K	962K	-40.69%2.77M	4.67M
Selling and administrative expenses	227.45%2.91M	391.12%2.32M	105.73%1.22M	--889K	--473K	--593K	-0.68%1.29M	--1.3M
-General and administrative expense	227.45%2.91M	391.12%2.32M	105.73%1.22M	--889K	--473K	--593K	-0.68%1.29M	--1.3M
Research and development costs	300.50%2.42M	232.78%1.59M	177.19%1.11M	--603K	--479K	--399K	-58.59%1.57M	--3.8M
Other operating expenses	51.72%-14K	-628.57%-51K	83.33%-5K	---29K	---7K	---30K	78.50%-91.5K	---425.57K
Operating profit	-263.09%-5.31M	-309.10%-3.87M	-141.27%-2.32M	-1.46M	-945K	-962K	-39.16%-2.27M	-1.63M
Net non-operating interest income expense	84.00%-16K	-124.07%-242K	-15.12%-99K	-100K	-108K	-86K	-281.85%-14.12K	7.77K
Non-operating interest income	----	----	----	----	----	----	-83.82%1.76K	--10.86K
Non-operating interest expense	-84.00%16K	124.07%242K	15.12%99K	--100K	--108K	--86K	413.19%15.88K	--3.09K
Other net income (expense)	102.44%6.71M	398.93%9.29M	-359.31%-7.02M	3.32M	1.86M	2.71M	-210.75%-397.62K	359.04K
Gain on sale of security	107.76%6.67M	399.41%9.29M	-359.31%-7.02M	--3.21M	--1.86M	--2.71M	-300.52%-398.7K	--198.84K
Special income (charges)	----	----	----	----	----	----	--0	--160.21K
-Less:Other special charges	----	----	----	----	----	----	----	---187.13K
-Gain on sale of business	----	----	----	----	----	----	--0	---26.93K
Other non- operating income (expenses)	-60.00%42K	---9K	----	--105K	----	----	--1.08K	----
Income before tax	-21.06%1.38M	540.72%5.18M	-669.18%-9.44M	1.75M	808K	1.66M	-112.07%-2.68M	-1.26M
Income tax
Net income	-21.06%1.38M	540.72%5.18M	-669.18%-9.44M	1.75M	808K	1.66M	-112.07%-2.68M	-1.26M
Net income continuous Operations	-21.06%1.38M	540.72%5.18M	-669.18%-9.44M	--1.75M	--808K	--1.66M	-112.07%-2.68M	---1.26M
Minority interest income	-27K	-27K		0	0
Net income attributable to the parent company	-19.52%1.41M	544.06%5.2M	-669.18%-9.44M	1.75M	808K	1.66M	-112.07%-2.68M	-1.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-19.52%1.41M	544.06%5.2M	-669.18%-9.44M	1.75M	808K	1.66M	-112.07%-2.68M	-1.26M
Basic earnings per share	-80.00%0.16	65.33%0.61	-538.96%-3.38	0.8	0.369	0.77	-112.07%-1.2326	-0.5812
Diluted earnings per share	-43.48%0.13	366.00%0.51	-1,790.00%-3.38	0.23	0.1094	0.2	-112.07%-1.2326	-0.5812
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data